Article Abstract

Erythropoietin and cancer - a poorly understood liaison!

Authors: Günter Weiss


Human recombinant erythropoietin (rhEpo) has been used for many years to treat chemotherapy and cancer associated anemia. The application of rhEpo resulted in an improved quality of life of patients and in a sparing of blood transfusions (1).


  • There are currently no refbacks.